These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22692856)

  • 1. Leptin regulates cyclin D1 in luminal epithelial cells of mouse MMTV-Wnt-1 mammary tumors.
    Zheng Q; Hursting SD; Reizes O
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1607-12. PubMed ID: 22692856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival.
    Zheng Q; Dunlap SM; Zhu J; Downs-Kelly E; Rich J; Hursting SD; Berger NA; Reizes O
    Endocr Relat Cancer; 2011 Aug; 18(4):491-503. PubMed ID: 21636700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors.
    Easter SL; Mitchell EH; Baxley SE; Desmond R; Frost AR; Serra R
    PLoS One; 2014; 9(11):e113247. PubMed ID: 25401739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
    Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S
    Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
    BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors.
    Paul R; Luo M; Mo X; Lu J; Yeo SK; Guan JL
    Breast Cancer Res; 2020 Jun; 22(1):59. PubMed ID: 32493400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin receptor-deficient MMTV-TGF-alpha/Lepr(db)Lepr(db) female mice do not develop oncogene-induced mammary tumors.
    Cleary MP; Juneja SC; Phillips FC; Hu X; Grande JP; Maihle NJ
    Exp Biol Med (Maywood); 2004 Feb; 229(2):182-93. PubMed ID: 14734797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
    Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
    Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
    Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.
    Hosokawa Y; Papanikolaou A; Cardiff RD; Yoshimoto K; Bernstein M; Wang TC; Schmidt EV; Arnold A
    Transgenic Res; 2001 Oct; 10(5):471-8. PubMed ID: 11708657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice.
    Ashad-Bishop K; Garikapati K; Lindley LE; Jorda M; Briegel KJ
    Biochem Biophys Res Commun; 2019 Jan; 508(2):536-542. PubMed ID: 30509497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity.
    Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM
    Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.
    Shin DH; Jang SH; Kang BC; Kim HJ; Oh SH; Kong G
    J Cell Physiol; 2011 May; 226(5):1340-52. PubMed ID: 20945346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
    Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
    Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 kinase activity is required for the self-renewal of mammary stem and progenitor cells that are targets of MMTV-ErbB2 tumorigenesis.
    Jeselsohn R; Brown NE; Arendt L; Klebba I; Hu MG; Kuperwasser C; Hinds PW
    Cancer Cell; 2010 Jan; 17(1):65-76. PubMed ID: 20129248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.
    Lenferink AE; Simpson JF; Shawver LK; Coffey RJ; Forbes JT; Arteaga CL
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9609-14. PubMed ID: 10931950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage.
    Zhu M; Yi M; Kim CH; Deng C; Li Y; Medina D; Stephens RM; Green JE
    Genome Biol; 2011 Aug; 12(8):R77. PubMed ID: 21846369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
    Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
    Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammary tumors initiated by constitutive Cdk2 activation contain an invasive basal-like component.
    Corsino PE; Davis BJ; Nørgaard PH; Parker NN; Law M; Dunn W; Law BK
    Neoplasia; 2008 Nov; 10(11):1240-52. PubMed ID: 18953433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.